Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Security class unavailable · CUSIP: 921659108
Event date: 2015-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,321,556
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-15-000343
- Form type
- SC 13G
- Filer
- Stonepine Capital Management, LLC
- CIK
- CIK 1440771
- Filed
- Jul 02, 2015
- Reporting period
- Jun 22, 2015
- Description
- Schedule 13G beneficial ownership